Key result
Wireless closed-loop optogenetics autonomously detects and terminates ventricular tachycardia in preclinical models.
Why the study?
Conventional electrical defibrillation for ventricular tachycardia causes pain and tissue damage, and prior optogenetic studies were limited to tethered or ex vivo models preventing ambulatory research.
Does a wireless, closed-loop optoelectronic platform autonomously detect and terminate induced ventricular tachycardia using targeted light stimulation in optogenetically modified rats?
Does a wireless, closed-loop optoelectronic platform autonomously detect and terminate induced ventricular tachycardia using targeted light stimulation in optogenetically modified rats?
A novel fully wireless closed-loop optoelectronic platform successfully provided shock-free, automated termination of ventricular tachycardia in a rodent model, marking a critical step for preclinical bioelectronic and mechanistic arrhythmia studies.
Answers are grounded in this paper and cite their sources.
Enables ambulatory optogenetic VT studies in rodents; extends tethered models but leaves open clinical translation.
Conventional electrical defibrillation for ventricular tachycardia (VT) can be painful and tissue damaging from non-selective high-voltage shocks. Optogenetics provides a cell-type-specific, shock-free alternative, but prior studies were limited to tethered or ex vivo models, preventing ambulatory studies. We developed a lightweight, fully wireless, closed-loop optoelectronic platform for rodents by combining continuous ECG monitoring, real-time arrhythmia detection, inductive power transfer, and high-power optical stimulation. This platform autonomously detects arrhythmic events and delivers optical interventions for shock-free arrhythmia termination. Wireless power transfer can continuously deliver 1.28 W to four high-power LEDs for optogenetic cardiac modulation. Simulations and benchtop testing validated functionality and safety. The modular design allows future extensions, enabling versatile chronic protocols. In vivo demonstrations in anesthetized, optogenetically modified rats validated the platform: VT was induced, detected within seconds, and autonomously terminated using light. Designed for freely moving animals, this platform advances mechanistic arrhythmia studies and the preclinical development of shock-free bioelectronic therapies.
No takes yet. Share an insight, caveat, or question.
Ouden et al. (2026) studied Ventricular tachycardia. Wireless, closed-loop optoelectronic platform for optogenetic termination was evaluated on Detection and autonomous termination of ventricular tachycardia. A wireless, closed-loop optoelectronic platform autonomously detected induced ventricular tachycardia within seconds and successfully terminated it using light in anesthetized, optogenetically modified rats.
Synapse has enriched 10 related papers. Consider them for comparative context: